A new drug for Alzheimer's disease has been developed by UK researchers, in a move that could lead to a treatment for the disease, media reports have claimed.
Tests revealed that the drug, CPHPC, could successfully remove the build-up of serum amyloid P component protein (SAP) from inside the brains of Alzheimer's sufferers.
A build up of SAP is often present in patients with Alzheimer's
Read more...